Understanding how immune responses affect blood platelet levels
Molecular Mechanisms of Immune Thrombocytopenia in Transfusion Medicine
This study is looking into how the immune system affects low platelet counts and blood clotting issues, with the goal of finding better treatments for people of all ages, from newborns to adults.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versiti Wisconsin, INC. NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-10934140 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms behind immune-mediated conditions that lead to low platelet counts and blood clotting disorders. It involves a collaborative effort between experts in platelet immunology and B cell biology, focusing on how these immune responses can impact patients of all ages, including newborns and adults. The research aims to uncover the underlying causes of these conditions to improve treatment options and patient outcomes in transfusion medicine.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with immune-mediated thrombocytopenia or related thrombotic disorders, spanning from newborns to adults.
Not a fit: Patients with non-immune related causes of low platelet counts or those without any blood disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better management and treatment strategies for patients suffering from immune-related blood disorders.
How similar studies have performed: Previous research in platelet immunology and related fields has shown promise in understanding and treating similar conditions, indicating a strong foundation for this investigation.
Where this research is happening
Milwaukee, United States
- Versiti Wisconsin, INC. — Milwaukee, United States (Active)
Researchers
- Principal investigator: Newman, Peter J — Versiti Wisconsin, INC.
- Study coordinator: Newman, Peter J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.